103 related articles for article (PubMed ID: 4369018)
1. Plasma adenosine 3',5'-cyclic monophosphate in human hypertension.
Hamet P; Kuchel O; Fraysse J; Genest J
Can Med Assoc J; 1974 Aug; 111(4):323-8. PubMed ID: 4369018
[TBL] [Abstract][Full Text] [Related]
2. Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essentrial hypertension.
Hamet P; Kuchel O; Cuche JL; Boucher R; Genest J
Can Med Assoc J; 1973 Dec; 109(11):1099-103. PubMed ID: 4357222
[TBL] [Abstract][Full Text] [Related]
3. Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.
Kuchel O; Messerli FH; Tolis G; Hamet P; Fraysse J; Cartier P; Roy P; Boucher R; Genest J
Can Med Assoc J; 1977 May; 116(9):992-6. PubMed ID: 192429
[TBL] [Abstract][Full Text] [Related]
4. Urinary and plasma cyclic adenosine 3',5'-monophosphate in patients with idiopathic edema.
Kuchel O; Hamet P; Cuche JL; Tolis G; Fraysse J; Genest J
J Clin Endocrinol Metab; 1975 Aug; 41(2):282-9. PubMed ID: 169278
[TBL] [Abstract][Full Text] [Related]
5. Labile (borderline) hypertension--new aspects of a common disorder.
Kuchel O; Cuche JL; Hamet P; Tolis G; Messerli FH; Barbeau A; Boucher R; Genest J
Angiology; 1975 Sep; 26(8):619-31. PubMed ID: 233754
[TBL] [Abstract][Full Text] [Related]
6. Effect of upright posture and isoproterenol infusion on cyclic adenosine monophosphate excretion in control subjects and patients with labile hypertension.
Hamet P; Kuchel O; Genest J
J Clin Endocrinol Metab; 1973 Feb; 36(2):218-26. PubMed ID: 4345690
[No Abstract] [Full Text] [Related]
7. Plasma cyclic adenosine 3':5'-monophosphate response to isoproterenol and glucagon in hyperkinetic borderline (labile) hypertension.
Messerli FH; Kuchel O; Hamet P; Tolis G; Guthrie GP; Fraysse J; Nowaczynski W; Genest J
Circ Res; 1976 Jun; 38(6 Suppl 2):42-7. PubMed ID: 178467
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral atenolol and propranolol on blood pressure, heart rate and plasma cyclic adenosine 3':5'-monophosphate in borderline hypertensive patients.
González-Gómez A; García-Barreto D; Cabrera R; Toruncha A; Hernández-Cañero A
Pharmacology; 1982; 25(1):33-8. PubMed ID: 6289362
[TBL] [Abstract][Full Text] [Related]
9. [Labile essential hypertension. The effect of Isoprenaline Spofa on plasma level of cyclic adenosine monophosphate].
Prikryl P; Rysánek K; Kunovská V; Bílková B; Továrek J; Cechovský K
Cas Lek Cesk; 1982 Aug; 121(33):1031-4. PubMed ID: 6290067
[No Abstract] [Full Text] [Related]
10. Catecholamines-cyclic amp-angiotensin receptors. Plasma catecholamine concentrations in patients with hypertension.
Engelman K; Portnoy B; Sjoerdsma A
Circ Res; 1970 Jul; 27(1 Suppl 1):141-6. PubMed ID: 4316356
[No Abstract] [Full Text] [Related]
11. Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension.
Petrov VV; Arabidze CG; Levitsky DO; Eliseev AO; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):153-7. PubMed ID: 8007744
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of cyclic nucleotides in patients with essential hypertension.
Tsuchiya S; Ogawa K; Satake T
Jpn Heart J; 1980 Nov; 21(6):803-15. PubMed ID: 6257942
[TBL] [Abstract][Full Text] [Related]
13. [Labile hypertension: hormonal characteristic and implications of the "second messenger"].
Kuchel O; Cuche JL; Hamet P; Barbeau A; Boucher R; Genest J
Union Med Can; 1973 Dec; 102(12):2458-70. PubMed ID: 4359087
[No Abstract] [Full Text] [Related]
14. Effects of beta-adrenergic blockade on plasma cyclic AMP and blood sugar responses to glucagon and isoproterenol in man.
Messerli FH; Kuchel O; Tolis G; Hamet P; Fraysse J; Genest J
Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):189-94. PubMed ID: 187546
[TBL] [Abstract][Full Text] [Related]
15. Effect of posture on renal vein renin activity in hypertension; its implications in the management of patients with renovascular hypertension.
Michelakis AM; Simmons J
JAMA; 1969 Apr; 208(4):659-62. PubMed ID: 5818565
[No Abstract] [Full Text] [Related]
16. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.
Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP
Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II plasma levels in hypertensive patients.
Fyhrquist F; Kala R; Standertskiöld-Nordensta ; Eisalo A
Acta Med Scand; 1972 Dec; 192(6):507-11. PubMed ID: 4344949
[No Abstract] [Full Text] [Related]
18. [Plasma renin activity in peripheral venous blood under various stimulation conditions].
Endres P; Siegenthaler W; Baumann K; Gysling E; Rubli H; Schönbeck M; Weidmann P; Werning C
Dtsch Med Wochenschr; 1969 May; 94(20):1049-57. PubMed ID: 4305855
[No Abstract] [Full Text] [Related]
19. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of hypoglycemia on plasma renin activity and cyclic adenosine 3',5'-monophosphate (cyclic AMP) in low renin and normal renin essential hypertension.
Lowder SC; Hamet P; Liddle GW
Circ Res; 1976 Feb; 38(2):105-8. PubMed ID: 173476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
